Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schneck

Showing results (71-80 of 164) with videos related to

Pageof 17
Sort By:
Journal of Immunological Methods|September 6, 2002
Probing T cell membrane organization using dimeric MHC-Ig complexesTarek M Fahmy, Joan G Bieler, Jonathan P Schneck
Nanomedicine : Nanotechnology, Biology, and Medicine|March 24, 2007
A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T cellsTarek M Fahmy, Jonathan P Schneck, W Mark Saltzman
Journal of Proteome Research|September 15, 2010
Novel cellular microarray assay for profiling T-cell peptide antigen specificitiesC Yue, M Oelke, M E Paulaitis, et al.
Journal of Molecular Recognition : JMR|November 10, 2006
Detection of antigen-specific T cells on p/MHC microarraysGokhan Deviren, Kapil Gupta, Michael E Paulaitis, et al.
Small Science|April 11, 2025
Nanoparticle Targeting Strategies for Lipid and Polymer-Based Gene Delivery to Immune Cells In VivoManav Jain, Xinjie Yu, Jonathan P Schneck, et al.
Current Protocols in Protein Science|March 15, 2011
High-throughput lectin microarray-based analysis of live cell surface glycosylationYu Li, Sheng-Ce Tao, Heng Zhu, et al.
Trends in Molecular Medicine|August 17, 2005
Artificial antigen-presenting cells: artificial solutions for real diseasesMathias Oelke, Christine Krueger, Robert L Giuntoli, et al.
Life Sciences|August 14, 2018
Soluble MHC class I complexes for targeted immunotherapyAnna Schappert, Jonathan P Schneck, Lauren Suarez, et al.
Nano Letters|March 1, 2018
Separating T Cell Targeting Components onto Magnetically Clustered Nanoparticles Boosts ActivationAlyssa K Kosmides, Kevin Necochea, John W Hickey, et al.
Biomaterials|October 9, 2013
Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cellsJoel C Sunshine, Karlo Perica, Jonathan P Schneck, et al.
Pageof 17

Showing results (71-80 of 164) with videos related to

Sort By:
Pageof 17
Journal of Immunological Methods|September 6, 2002
Probing T cell membrane organization using dimeric MHC-Ig complexesTarek M Fahmy, Joan G Bieler, Jonathan P Schneck
Nanomedicine : Nanotechnology, Biology, and Medicine|March 24, 2007
A nanoscopic multivalent antigen-presenting carrier for sensitive detection and drug delivery to T cellsTarek M Fahmy, Jonathan P Schneck, W Mark Saltzman
Journal of Proteome Research|September 15, 2010
Novel cellular microarray assay for profiling T-cell peptide antigen specificitiesC Yue, M Oelke, M E Paulaitis, et al.
Journal of Molecular Recognition : JMR|November 10, 2006
Detection of antigen-specific T cells on p/MHC microarraysGokhan Deviren, Kapil Gupta, Michael E Paulaitis, et al.
Small Science|April 11, 2025
Nanoparticle Targeting Strategies for Lipid and Polymer-Based Gene Delivery to Immune Cells In VivoManav Jain, Xinjie Yu, Jonathan P Schneck, et al.
Current Protocols in Protein Science|March 15, 2011
High-throughput lectin microarray-based analysis of live cell surface glycosylationYu Li, Sheng-Ce Tao, Heng Zhu, et al.
Trends in Molecular Medicine|August 17, 2005
Artificial antigen-presenting cells: artificial solutions for real diseasesMathias Oelke, Christine Krueger, Robert L Giuntoli, et al.
Life Sciences|August 14, 2018
Soluble MHC class I complexes for targeted immunotherapyAnna Schappert, Jonathan P Schneck, Lauren Suarez, et al.
Nano Letters|March 1, 2018
Separating T Cell Targeting Components onto Magnetically Clustered Nanoparticles Boosts ActivationAlyssa K Kosmides, Kevin Necochea, John W Hickey, et al.
Biomaterials|October 9, 2013
Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cellsJoel C Sunshine, Karlo Perica, Jonathan P Schneck, et al.
Pageof 17